Firms & Funds Fund performance: Mid-life funds benefit from biotech, tech upswings Mark Boslet - September 15 2015 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
